Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Volume

I was not discussing management.I was only discussing the apparent strength of the MMP and timely negative posts immediately following said re-certs.If you wish to constantly berate the BOD,so be it.My focus is toward an amicable settlement with all involved.That is the only,and I repeat,the only avenue to appreciate the returns on the patents

It is because of the strengthening MMP subsequent to each recertification that will assist in what ronran, myself, and countless others are looking for: a steady and more predictable revenue stream, in my very humble opinion.

As ronran sagely pointed out, it is this that will move the price upwards.

The BoD have already stated that M&A activity has been halted, so any licensing revenues will give rise to ever-increasing cash reserves, which in turn will also assist the share price. Once the reserves have reached an optimum value there comes the possiblity of dividend payments.

The recerts are therefore important, and should be viewed with far more positivity than currently, in my opinion.

Be well

Share
New Message
Please login to post a reply